Ropivacaine
Naropin, Ropivacaine (ropivacaine) is a small molecule pharmaceutical. Ropivacaine was first approved as Naropin on 1996-09-24. It is used to treat postoperative pain in the USA. It is known to target sodium channel protein type 5 subunit alpha.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
Naropin, Ropivacaine (discontinued: Naropin, Ropivacaine)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ropivacaine hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| NAROPIN | Fresenius Kabi | N-020533 RX | 1996-09-24 | 11 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| naropin | New Drug Application | 2026-07-22 |
| naropin naropin | New Drug Application | 2018-08-02 |
| readyfusor ropivacaine | Export only | 2018-06-22 |
| ropidex | unapproved drug other | 2024-10-04 |
| ropivacaine hydrochloride | ANDA | 2026-05-20 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| postoperative pain | — | D010149 | G89.18 |
Agency Specific
FDA
EMA
No data
HCPCS
Code | Description |
|---|---|
| J2795 | Injection, ropivacaine hydrochloride, 1 mg |
Clinical
Clinical Trials
2109 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postoperative pain | D010149 | — | G89.18 | 14 | 28 | 48 | 182 | 323 | 586 |
| Pain | D010146 | EFO_0003843 | R52 | 10 | 9 | 18 | 50 | 77 | 159 |
| Replacement arthroplasty knee | D019645 | — | — | 3 | 6 | 6 | 41 | 45 | 98 |
| Agnosia | D000377 | EFO_0007136 | F88 | 1 | 5 | 13 | 21 | 56 | 94 |
| Nerve block | D009407 | — | — | 3 | 2 | 2 | 20 | 55 | 82 |
| Analgesia | D000698 | — | — | — | 6 | 6 | 14 | 52 | 78 |
| Local anesthesia | D000772 | — | — | 3 | 3 | 6 | 16 | 39 | 66 |
| Anesthesia | D000758 | — | — | 1 | 3 | 4 | 16 | 39 | 61 |
| Conduction anesthesia | D000765 | — | — | 1 | 1 | 1 | 10 | 46 | 59 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 1 | 3 | 3 | 27 | 26 | 58 |
Show 251 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ganglion cysts | D045888 | — | M67.4 | — | 1 | 2 | — | 10 | 13 |
| Neoplasms | D009369 | — | C80 | — | 2 | 2 | — | 8 | 12 |
| Hepatectomy | D006498 | — | — | — | — | 1 | — | 10 | 11 |
| Hypotension | D007022 | EFO_0005251 | I95 | 1 | 3 | 3 | — | 6 | 10 |
| Musculoskeletal diseases | D009140 | — | — | — | 4 | 3 | — | 6 | 10 |
| Low back pain | D017116 | — | M54.5 | — | 1 | 1 | — | 5 | 7 |
| Synovial cyst | D013581 | — | M71.3 | — | — | 2 | — | 5 | 7 |
| Ambulatory surgical procedures | D000556 | — | — | — | 1 | 2 | — | 4 | 6 |
| Urinary bladder neoplasms | D001749 | — | C67 | — | — | 1 | — | 4 | 5 |
| Post-dural puncture headache | D051299 | — | — | — | — | 1 | — | 4 | 5 |
Show 45 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | 1 | 3 | — | — | 6 | 10 |
| Subarachnoid hemorrhage | D013345 | EFO_0000713 | I60 | — | 1 | — | — | 4 | 5 |
| Back pain | D001416 | — | M54 | 1 | 1 | — | — | 3 | 4 |
| Plastic surgery procedures | D019651 | — | — | — | 1 | — | — | 2 | 3 |
| Nausea | D009325 | — | R11.0 | — | 1 | — | — | 2 | 3 |
| Dentofacial deformities | D063169 | — | — | — | 1 | — | — | 2 | 3 |
| Traumatic stress disorders | D040921 | — | — | 1 | 2 | — | — | — | 3 |
| Shoulder fractures | D012784 | — | S42.9 | — | 1 | — | — | 2 | 3 |
| Leiomyoma | D007889 | — | D25 | — | 1 | — | — | 2 | 3 |
| Soft tissue neoplasms | D012983 | — | — | — | 1 | — | — | 1 | 2 |
Show 19 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Paralysis | D010243 | — | — | 1 | — | — | — | 7 | 8 |
| Male circumcision | D002944 | EFO_0003953 | — | 1 | — | — | — | 4 | 5 |
| Craniotomy | D003399 | — | — | 1 | — | — | — | 2 | 3 |
| Vulvar diseases | D014845 | — | — | 1 | — | — | — | 1 | 2 |
| Uterine myomectomy | D063186 | — | — | 1 | — | — | — | 1 | 2 |
| Plantar fasciitis | D036981 | EFO_1001909 | M72.2 | 1 | — | — | — | — | 1 |
| Clostridium botulinum type a | D047013 | — | — | 1 | — | — | — | — | 1 |
| Coronary occlusion | D054059 | — | I21 | 1 | — | — | — | — | 1 |
| Topical administration | D000287 | — | — | 1 | — | — | — | — | 1 |
| Fatigue | D005221 | — | R53.83 | 1 | — | — | — | — | 1 |
Show 5 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cognitive dysfunction | D060825 | — | G31.84 | — | — | — | — | 5 | 5 |
| Esophageal neoplasms | D004938 | — | C15 | — | — | — | — | 4 | 4 |
| Thoracic injuries | D013898 | — | S20-S29 | — | — | — | — | 4 | 4 |
| Ventral hernia | D006555 | EFO_1001866 | K43 | — | — | — | — | 4 | 4 |
| Diabetic foot | D017719 | EFO_1001459 | — | — | — | — | — | 4 | 4 |
| Acrodynia | D000170 | EFO_1001756 | — | — | — | — | — | 4 | 4 |
| Aortic valve stenosis | D001024 | EFO_0000266 | — | — | — | — | — | 3 | 3 |
| Cryptorchidism | D003456 | EFO_0004562 | Q53.1 | — | — | — | — | 3 | 3 |
| Parasomnias | D020447 | — | G47.5 | — | — | — | — | 3 | 3 |
| Aneurysm | D000783 | — | I72.9 | — | — | — | — | 3 | 3 |
Show 228 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Ropivacaine |
| INN | ropivacaine |
| Description | (S)-ropivacaine is a piperidinecarboxamide-based amide-type local anaesthetic (amide caine) in which (S)-N-propylpipecolic acid and 2,6-dimethylaniline are combined to form the amide bond. It has a role as a local anaesthetic. It is a piperidinecarboxamide and a ropivacaine. |
| Classification | Small molecule |
| Drug class | local anesthetics |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C |
Identifiers
| PDB | — |
| CAS-ID | 84057-95-4 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1077896 |
| ChEBI ID | 8890 |
| PubChem CID | 175805 |
| DrugBank | DB00296 |
| UNII ID | 7IO5LYA57N (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
SCN5A
SCN5A
Organism
Homo sapiens
Gene name
SCN5A
Gene synonyms
NCBI Gene ID
Protein name
sodium channel protein type 5 subunit alpha
Protein synonyms
cardiac tetrodotoxin-insensitive voltage-dependent sodium channel alpha subunit, hH1, Sodium channel protein cardiac muscle subunit alpha, Sodium channel protein type V subunit alpha, sodium channel, voltage-gated, type V, alpha subunit, Voltage-gated sodium channel subunit alpha Nav1.5
Uniprot ID
Mouse ortholog
Scn5a (20271)
sodium channel protein type 5 subunit alpha (Q9JJV9)
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
4,174 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use